{"filings":[{"id":2447556,"accession_number":"0001213900-26-093220","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2026-08-25T10:06:43+00:00","items":["8.01","7.01","9.01"],"status":"ready","headline":"RMTG Q1 revenue up 90% YoY, Q2 quadrupled; Argentina license, Cancun lab expansion","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Q1 2026 revenue up 90% YoY; Q2 revenue quadrupled YoY; 2025 total revenue $5.1M.","Argentina granted first-ever license to harvest/produce biologics; Cancun lab added 2 clean rooms with COFEPRIS sign-off.","ISSCA AI launched with 30 years of 60M redacted patient records to power physician tool.","BKFC partnership continues; fighter Ben Rothwell treated; more announcements expected.","Company evaluating capital raising strategies; may increase authorized shares; Nasdaq uplisting desired but no timeline."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159094,"accession_number":"0001213900-25-046203","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2025-05-21T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RMTG Q1 sales up 67% to $1.35M; achieves operating profit of $134K","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 revenue $1.35M, a 67% increase over Q1 2024.","Operating profit of $134,000 for the quarter; positive cash flow noted.","New Turnkey membership revenue stream: clinics pay upfront fee and exclusive purchasing.","RMTG plans one new member per quarter initially, accelerating next year.","CEO expects continued revenue growth and sustained operating income; formal guidance forthcoming."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.06,"consensus_revenue_estimate":null,"consensus_revenue_actual":1364341.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194253,"accession_number":"0001213900-24-099837","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2024-11-19T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"RMTG reports Q3 sales up 52% YoY, achieves operational profitability, gross margin 75%","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Sales rose 52% YoY to $986,308; gross profit margin reached 75% for Q3 2024.","Patient procedures revenue surged over 370% YoY, now 37% of revenue versus 12% last year.","Company achieved operational profitability, defined as revenue minus all operating expenses excluding interest and taxes.","Dubai clinic expected to launch next week; plans for a manufacturing facility in Cancun to produce exosomes and stem cells."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":194252,"accession_number":"0001213900-24-090248","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2024-10-24T23:59:59+00:00","items":["8.01"],"status":"ready","headline":"Meso Numismatics changes name to Regenerative Medical Technology Group, ticker to RMTG","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change to Regenerative Medical Technology Group Inc. effective Oct. 21, 2024 after FINRA processing.","New stock ticker symbol RMTG; CUSIP number unchanged.","Old stock certificates remain valid; new certificates issued upon exchange or transfer.","Previously disclosed in Schedule 14C; this 8-K confirms completion of corporate action."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":228920,"accession_number":"0001213900-24-046079","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2024-05-23T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Meso Numismatics reports positive operating cash flow >$100k in Q1 2024; proceeding with name change to RMTG","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Name change to Regenerative Medical Technology Group Inc. pending FINRA market effective date.","Positive cash from operations over $100k for the quarter ended March 31, 2024, per recent 10-Q.","New logo and authorized shares change near completion to reflect biotech focus.","Company transitions from numismatics to regenerative medicine, now a stem cell company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":265020,"accession_number":"0001213900-23-095384","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2023-12-13T23:59:59+00:00","items":["1.01","3.02","9.01"],"status":"ready","headline":"Meso Numismatics secures up to $10M equity financing from GHS Investments","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["GHS will purchase shares at 80% of market price (90% after up-list); puts up to $700K each over 24 months.","Company issued 50,000 commitment shares to GHS; also pays 2% placement agent fee to Icon Capital.","Beneficial ownership capped at 4.99%; no short selling by GHS; requires effective registration statement.","Company must file S-1 within 30 days; proceeds for general corporate purposes; stock traded on OTC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":282200,"accession_number":"0001213900-23-079657","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2023-09-27T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Meso Numismatics dismisses auditor, engages new firm; material weakness in internal controls persists","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed L J Soldinger Associates as independent auditor on Sept 22, 2023.","Engaged Victor Mokuolu, CPA PLLC as new independent auditor effective same day.","Prior audit reports (2021, 2022) had going-concern uncertainty but no adverse opinion.","Management identified material weakness in internal controls over financial reporting as of Dec 31, 2022, not yet remediated.","No disagreements with former accountant on accounting principles or practices."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":393490,"accession_number":"0001213900-22-014379","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K/A","filed_at":"2022-03-23T23:59:59+00:00","items":["2.01","1.01","3.02","5.01","5.02","8.01","9.01"],"status":"ready","headline":"Meso Numismatics completes acquisition of Global Stem Cells Group; financials show $105K net loss","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquisition closed Aug 18, 2021: Meso Numismatics acquires GCSC for 1M Series AA pref, 8,974 Series DD pref, and $225K.","Change in control: Benito Novas receives Series AA super-voting stock (67% aggregate vote); CEO Christensen holds 50K Series AA.","GCSC's audited financials: 2020 revenue $615K (down from $1.02M in 2019), net loss $105K; $461K cash, $459K liabilities.","Going concern opinion: GCSC has recurring losses and working capital deficit, raising substantial doubt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":412017,"accession_number":"0001213900-21-063148","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2021-12-02T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Meso Numismatics replaces auditor M&K CPAS with L J Soldinger; prior reports had going concern","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["M&K CPAS resigned as independent auditor on Nov 30, 2021; L J Soldinger Associates engaged on Dec 1, 2021.","Former auditor's reports for FY 2020 and 2019 contained a going concern qualification about the company's ability to continue.","No disagreements occurred, but a reportable event existed: ineffective internal controls over financial reporting as of Dec 31, 2020.","The company had not consulted the new accountant before engagement on any accounting or audit matters.","The former auditor's response letter was filed as Exhibit 16.1 with the SEC."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":430734,"accession_number":"0001213900-21-043755","cik":1760026,"company_name":"Regenerative Medical Technology Group Inc.","ticker":"RMTG","form_type":"8-K","filed_at":"2021-08-19T23:59:59+00:00","items":["1.01","2.01","3.02","5.01","5.02","8.01","9.01"],"status":"ready","headline":"Meso Numismatics closes Global Stem Cells Group acquisition; renegotiates $10.5M financing","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Acquired all GCSC shares for 1M Series AA Preferred, 8,974 Series DD Preferred, and $225,000 cash.","Issuance of 1M Series AA Preferred to Benito Novas caused change of control; Novas and CEO jointly control 67% vote.","Renegotiated June 2021 $10.5M financing: warrant maturity extended to 7 years, locked up for first 2 years.","$8.2M earmarked for Lans Holdings escrow per prior agreement.","Entered consulting agreement with ETC (owned by CEO) for 896 Series DD Preferred shares."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":478784.0,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}